INDICATION & USAGE

IXIARO is a vaccine indicated for the prevention of disease caused by Japanese encephalitis virus, approved for use in individuals 2 months of age and older.

Important Safety Information

Severe allergic reaction after a previous dose of IXIARO, any other Japanese encephalitis vaccine,  or any component of IXIARO, including protamine sulfate a compound known to cause hypersensitivity reactions in some individuals is a contraindication to administration of IXIARO.  Individuals with a history of severe allergic reaction to another Japanese encephalitis vaccine may be referred to an allergist for evaluation if immunization with IXIARO is considered.

Vaccination with IXIARO may not protect all individuals.  Individuals with a weakened immune system may have a diminished immune response to IXIARO.  Fainting may occur when receiving any injection, including IXIARO.  Tell your healthcare practitioner if you have a history of fainting from injections.

The most common (>10%) adverse reactions were: fever, irritability, diarrhea, and injection site redness in infants 2 months to <1 year of age; fever in children 1 to <12 years of age; pain and tenderness in adolescents 12 to <18 years of age; and, headache, muscle pain, and injection site pain and tenderness in adults.

You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit www.vaers.hhs.gov or call 1-800-822-7967.  You should ask your healthcare practitioner for medical advice about adverse events.

For more information, please see the physician’s Prescribing Information and ask your healthcare practitioner about the risk and benefits of IXIARO.

    

INDICATION & USAGE

IXIARO is a vaccine indicated for the prevention of disease caused by Japanese encephalitis virus, approved for use in individuals 2 months of age and older.

Important Safety Information

Severe allergic reaction after a previous dose of IXIARO, any other Japanese encephalitis vaccine,  or any component of IXIARO, including protamine sulfate  a compound known to cause hypersensitivity reactions in some individuals  is a contraindication to administration of IXIARO.  Individuals with a history of severe allergic reaction to another Japanese encephalitis vaccine may be referred to an allergist for evaluation if immunization with IXIARO is considered.

Vaccination with IXIARO may not protect all individuals.  Individuals with a weakened immune system may have a diminished immune response to IXIARO.  Fainting may occur when receiving any injection, including IXIARO.  Tell your healthcare practitioner if you have a history of fainting from injections.

The most common (>10%) adverse reactions were: fever, irritability, diarrhea, and injection site redness in infants 2 months to <1 year of age; fever in children 1 to <12 years of age; pain and tenderness in adolescents 12 to <18 years of age; and, headache, muscle pain, and injection site pain and tenderness in adults.

You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit www.vaers.hhs.gov or call 1-800-822-7967.  You should ask your healthcare practitioner for medical advice about adverse events.

For more information, please see the physician’s Prescribing Information and ask your healthcare practitioner about the risk and benefits of IXIARO.

    

 

 

 

Thailand

Vietnam

Vietnam

Traveling’s in your blood? 

Make sure it’s the only thing!

Mosquitos are a crafty bunch. Even if you’ve taken every precaution to fight against them, they can be pretty difficult to avoid.

If you’re headed to Asia or the western Pacific, IXIARO is a safe way to help protect yourself from Japanese encephalitis. It’s been used across Europe and the US since 2009.

IXIARO® is a vaccine indicated for the prevention of disease caused by Japanese encephalitis (JE) virus for people 2 months
of age and older.

 

IXIARO® is a vaccine indicated for the prevention of disease caused by Japanese encephalitis (JE) virus for people 2 months
of age and older.

IXIARO® is a vaccine indicated for the prevention of disease caused by Japanese encephalitis (JE) virus for people 2 months of age and older.

The most common side effects include fever, irritability, diarrhea, and injection site redness in those up to 1 year of age; fever in children up to age 12; and pain and tenderness in adolescents. In adults the most common side effects are headache, muscle pain, and injection site pain and tenderness.

IS VACCINATION RIGHT FOR YOU?

  • Do you travel frequently to Asia, are you planning a long trip (e.g., a month), or will you be taking up residence?
  • Is it possible you might participate in unplanned excursions and/or activities (i.e., something you would learn about once you’re there)?
  • Will you be spending time outdoors (day or night) sight-seeing, exploring, hiking, fishing, biking, camping, etc.?
  • Is there a chance you’ll be staying in accommodations without air conditioning, screens or bed nets?

If you can say yes to any of the above, contact a travel health professional.

If you’re only planning to be in Asia for a short amount of time, like a quick visit to Hong Kong or Singapore, and you’re sure you won’t be stepping outside city limits, then you probably don’t need to get vaccinated. But you should definitely confirm this with a travel health professional.

Travel like a local, but make sure to protect yourself like one, too.

Indication & Usage

IXIARO is a vaccine indicated for the prevention of disease caused by Japanese encephalitis virus, approved for use in individuals 2 months of age and older.

Important Safety Information

Severe allergic reaction after a previous dose of IXIARO, other Japanese encephalitis vaccine, any or any component of IXIARO, including protamine sulfate ─ a compound known to cause hypersensitivity reactions in some individuals ─ is a contraindication to administration of IXIARO. Individuals with a history of severe allergic reaction to another Japanese Encephalitis vaccine may be referred to an allergist for evaluation if immunization with IXIARO is considered.

Vaccination with IXIARO may not protect all individuals. Individuals with a weakened immune system may have a diminished immune response to IXIARO. Fainting may occur when receiving any injection, including IXIARO. Tell your healthcare practitioner if you have a history of fainting from injections.

The most common (>10%) adverse reactions were: fever, irritability, diarrhea, and injection site redness in infants 2 months to <1 year of age; fever in children 1 to <12 years of age; pain and tenderness in adolescents 12 to <18 years of age; and, headache, muscle pain, and injection site pain and tenderness in adults.

You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit www.vaers.hhs.gov or call 1-800-822-7967. You should ask your healthcare practitioner for medical advice about adverse events.

For more information, please see the physician’s Prescribing Information and ask your healthcare practitioner about the risk and benefits of IXIARO.

 

 

Site is intended for travelers from the United States

US-IXI-2200027 | Copyright © 2022 Valneva USA, Inc. All Rights Reserved.